Merge pull request #52 from ehn-dcc-development/release/2.8.0

Release 2.8.0: guidelines document v1.10

CHANGELOG.md

@@ -1,5 +1,15 @@
 # Change log
 
+## Release 2.8.0
+
+* Update to eHN guidelines document for value sets, version 1.10:
+  1. Change of the name of one vaccine: Jcovden, formerly known as “COVID-19 Vaccine Janssen”
+  2. New vaccines: Soberana 02, and Soberana Plus
+  3. New vaccine marketing authorization holder or manufacturer: Finlay-Institute
+
+  The [guidelines document v1.10 has been adopted and published](https://ec.europa.eu/health/sites/default/files/ehealth/docs/digital-green-value-sets_en.pdf) through the [eHealth network page on the EU DCC](https://ec.europa.eu/health/ehealth/covid-19_en).
+
+
 ## Release 2.7.0
 
 * Update to eHN guidelines document for value sets, version 1.9:
@@ -20,6 +30,7 @@
         - Yisheng Biopharma
         - Sinocelltech Ltd.
         - Medicago Inc.
+    4. (Small adjustment to the values of the display name fields for Covaxin and Covishield.)
 
   The [guidelines document v1.9 has been adopted and published](https://ec.europa.eu/health/sites/default/files/ehealth/docs/digital-green-value-sets_en.pdf) through the [eHealth network page on the EU DCC](https://ec.europa.eu/health/ehealth/covid-19_en).
 

README.md

@@ -2,7 +2,7 @@
 
 This repository contains the value sets referenced by the EU Digital COVID Certificate (DCC) [JSON Schema](https://github.com/ehn-dcc-development/ehn-dcc-schema).
 
-Release: 2.7.0
+Release: 2.8.0
 
 Note that these value sets do not form a core part of the [JSON Schema](https://github.com/ehn-dcc-development/ehn-dcc-schema) but are referenced by it. These value sets can (and should) be regularly updated and distributed from the main Digital COVID Certificate Gateway (DCCG), under clear versioning and release management.
 

vaccine-mah-manf.json

@@ -204,6 +204,13 @@
       "active": true,
       "system": "https://spor.ema.europa.eu/v1/organisations",
       "version": ""
+    },
+    "Finlay-Institute": {
+      "display": "Finlay Institute of Vaccines",
+      "lang": "en",
+      "active": true,
+      "system": "http://ec.europa.eu/temp/vaccinemanufacturer",
+      "version": "1.10"
     }
   }
 }

vaccine-medicinal-product.json

@@ -24,7 +24,7 @@
       "version": ""
     },
     "EU/1/20/1525": {
-      "display": "COVID-19 Vaccine Janssen",
+      "display": "Jcovden",
       "lang": "en",
       "active": true,
       "system": "https://ec.europa.eu/health/documents/community-register/html/",
@@ -239,6 +239,20 @@
       "active": true,
       "system": "http://ec.europa.eu/temp/vaccineproductname",
       "version": "1.9"
+    },
+    "Soberana-02": {
+      "display": "Soberana 02",
+      "lang": "en",
+      "active": true,
+      "system": "http://ec.europa.eu/temp/vaccineproductname",
+      "version": "1.10"
+    },
+    "Soberana-Plus": {
+      "display": "Soberana Plus",
+      "lang": "en",
+      "active": true,
+      "system": "http://ec.europa.eu/temp/vaccineproductname",
+      "version": "1.10"
     }
   }
 }